Drug
Ins1201
Ins1201: highest development phase Phase 1, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| INS1201 NCT06817382 | Phase 1 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Ins1201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.